Pay in 4 interest-free payments of $6.67 Learn more
Ships within 48 hours · Estimated delivery Aug 13 - Aug 18
Emerging therapies such as AB1002 and RT100 aim to overcome past limitations and offer innovative approaches to modulating calcium cycling and cardiac contractility
However, you should be aware of some potentially serious side effects
SMPDL3b, sphingomyelin phosphodiesterase acid-like 3b
334 To explore its potential in high-risk populations, the ongoing KARDIA-3 trial (NCT06272487) is enrolling cardiovascular high-risk patients or those with advanced chronic kidney disease who are taking 24 antihypertensive agents
US$ 23.59
US$ 23.44
US$ 20.38
